Transplant Surgery

FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Roy D. Baynes, MD, PhD, will join the company as Senior Vice President, Oncology Therapeutics. In this position, Dr. Baynes will report...

--Middle Tennessee's only certified Destination Therapy program offers renewed hope and results for advanced heart failure patients-- NASHVILLE, Tenn. -- Saint Thomas Hospital, a member of Saint Thomas Health and a national leader...

NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that dosing has initiated in a Phase 1 study of its hematopoietic growth factor, CDX-301, in healthy subjects. The study is being conducted...

Wills Eye Institute receives IRB approval to treat dry-AMD using ACT's hESC-derived retinal pigment epithelial (RPE) cells MARLBOROUGH, Mass. -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2012. "Rexahn...

Federal health care law does not preempt an amendment to state law guaranteeing a medical malpractice plaintiff's right to know about prior adverse medical incidents, the Florida Supreme Court has ruled in affirming...

-Ganetespib and docetaxel display complementary cell cycle inhibition effects- -Combination of ganetespib with microtubule stabilizers (docetaxel and paclitaxel) or destabilizers (vincristine) results in synergistic anticancer activity- -Ganetespib and docetaxel combination currently being studied...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/36f374/singapore_medical) has announced the addition of the "Singapore Medical Tourism Industry Outlook to 2015" report to their offering. The report titled Singapore Medical Tourism Industry Outlook to 2015 provides...

ALACHUA, Fla. -- AxoGen, Inc. (OTCBB: AXGN), an emerging regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported the publication of peer-reviewed...

CHICAGO -- Corboy & Demetrio has secured a $2 million settlement on behalf of a Chicago woman who was hit by a garbage truck in the city's River North neighborhood. The truck was...

BOTHELL, Wash. -- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced updates to the U.S. Prescribing Information (PI) for ADCETRIS[TM] (brentuximab vedotin). The revised PI will include the following updated information: * A boxed...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/4174e6/graft_versus_host) has announced the addition of GlobalData's new report "Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the...

AUSTIN, Texas -- Under a new agreement, the Blood and Tissue Center of Central Texas will track all of its implantable tissue allografts with IMS' ReadyTracker-Tissue, a leading web-based application for tracking biologic...

Informational Portal Educates Patients, Public About Allograft Tissue ALACHUA, Fla. -- RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, has launched an informational website to educate...

LEWISVILLE, Texas -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today preliminary unaudited fourth quarter net sales are expected to be a record of approximately $151.3 million, increasing 5% over $143.8 million in...

ROCHESTER, Minn. -- Here are highlights from the January issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic...

Following a safety review of the heart drug Multaq, the Food and Drug Administration has recommended greater restrictions for the medication. Multaq was approved in July 2009 by the FDA for the treatment...

Collaboration to further validate the performance of RainDance's HLASeq[TM] Research Screening Panel LEXINGTON, Mass. -- RainDance Technologies, Inc., the Digital Biology[TM] Company, today announced that it is collaborating with the Hypital Saint-Louis in...

ALACHUA, Fla. -- AxoGen, Inc. (OTCBB: AXGN) today announced that it will be presenting at the Eighth Annual Noble Financial Equity Conference at the Hard Rock Hotel in Hollywood, Florida. Greg Freitag, AxoGen's...